Skip to main content
. 2016 Jun 2;7(30):46878–46889. doi: 10.18632/oncotarget.9795

Table 3. Top 12 significantly age acceleration related CpG sites in validation panel a.

CpG sites Genes Mean (SD)b Age acceleration (Horvath) Age acceleration (Hannum)
Correlation coefficientsc Effect size (SE)d p-value FDR Correlation coefficientsc Effect size (SE)d p-value FDR
cg03329539 2q37.1 0.38 (0.036) −0.23 −23.9 (6.0) 8.7 e-5 2.0 e-4 −0.27 −16.6 (4.5) 2.8 e-4 6.0 e-4
cg01899089 AHRR 0.49 (0.033) −0.30 −41.0 (5.6) 1.8 e-12 7.3 e-11 −0.33 −29.8 (4.3) 9.9 e-12 1.6 e-10
cg05575921 AHRR 0.85 (0.041) −0.21 −5.8 (2.1) 5.3 e-3 8.2 e-3 −0.25 −5.5 (1.5) 4.2 e-4 8.3 e-4
cg24090911 AHRR 0.73 (0.034) −0.20 −28.9 (5.8) 7.8 e-7 3.1 e-6 −0.33 −31.2 (4.2) 5.6 e-13 1.5 e-11
cg20295214 AVPR1B 0.76 (0.029) −0.26 −31.9 (6.6) 1.6 e-6 6.2 e-6 −0.27 −24.9 (4.9) 6.0 e-7 3.3 e-6
cg10190813 HUS1 0.17 (0.026) −0.25 −39.5 (9.5) 4.1 e-5 9.6 e-5 −0.23 −18.8 (7.4) 0.011 0.015
cg01744331 KCNQ1 0.90 (0.032) −0.21 −35.2 (6.9) 4.8 e-7 2.0 e-6 −0.25 −25.3 (5.3) 2.5 e-6 1.1 e-5
cg07123182 KCNQ1 0.93 (0.019) −0.20 −48.9 (8.7) 4.2 e-8 2.7 e-7 −0.25 −41.4 (6.5) 5.3 e-10 6.3 e-9
cg06595162 NCRNA00114 0.72 (0.026) −0.24 −48.5 (6.8) 1.5 e-12 7.3 e-11 −0.25 −34.7 (5.1) 4.7 e-11 6.5 e-10
cg04158018 NFE2 0.30 (0.040) −0.21 −24.5 (6.3) 1.1 e-4 2.3 e-4 −0.23 −20.8 (4.7) 9.4 e-6 3.3 e-5
cg25305703 0.65 (0.051) −0.29 −23.6 (3.5) 4.1 e-11 8.5 e-10 −0.36 −21.6 (2.5) 2.8 e-16 1.2 e-14
cg16201146 0.67 (0.045) −0.24 −37.9 (6.4) 7.4 e-9 6.2 e-8 −0.20 −41.5 (4.6) 9.7 e-18 8.1 e-16
a

12 loci with correlation coefficients ≤ −0.20;

b

Data of never smokers;

c

Spearman's Rank-Order Correlation coefficients;

d

Adjusted for age (years), gender, random batch effects, leukocyte distribution (Houseman algorithm [21]), alcohol consumption (abstainer/ low/ intermediate/ high), body mass index (BMI, underweight or normal weight/ overweight/ obese) and physical activity (inactive/ low/ medium or high); The beta coefficients from regression models were reported as effect sizes;